What does CUSIP 28658R106 represent in this 13F holders report?

CUSIP 28658R106 is the security identifier for CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

How many institutions held CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share in Q2 2023?

21 institutional investors reported CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share for Q2 2023. Use the holders table for investor-level position and value details.

Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM)

CUSIP: 28658R106

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 68,580,003
Total 13F shares: 16,730,361
Share change: +28,291
Total reported value: $46,844,345
Price per share: $2.80
Number of holders: 21
Value change: +$79,298
Number of buys: 8
Number of sells: 6

Quarterly Holders Quick Answers

What is CUSIP 28658R106?
CUSIP 28658R106 identifies CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 28658R106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
AI ETI LLC	3/4/5	10%+ Owner	— class O/S missing	5,009,400	$62,617,500	—	12 Aug 2021	3/4/5
RA CAPITAL MANAGEMENT, L.P.	13F	Company	19%	13,150,849	$38,137,462	—	31 Mar 2023	13F
BML Capital Management, LLC	13F	Company	2.4%	1,658,170	$4,808,693	—	31 Mar 2023	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.98%	673,684	$1,953,684	—	31 Mar 2023	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	0.71%	485,955	$1,409,270	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	0.4%	274,517	$796,099	—	31 Mar 2023	13F
Atom Investors LP	13F	Company	0.12%	78,886	$228,769	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.1%	67,621	$196,000	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.09%	64,014	$185,640	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.09%	62,316	$180,717	—	31 Mar 2023	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.08%	55,223	$160,147	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	0.05%	32,701	$94,834	—	31 Mar 2023	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.04%	29,706	$86,000	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.03%	19,800	$57,420	—	31 Mar 2023	13F
Chicago Partners Investment Group LLC	13F	Company	0.03%	18,520	$52,412	—	31 Mar 2023	13F
STIFEL FINANCIAL CORP	13F	Company	0.02%	14,862	$43,100	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.02%	11,247	$32,616	—	31 Mar 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	3,262	$9,000	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	695	$2,016	—	31 Mar 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	42	$122	—	31 Mar 2023	13F
Robert Azelby	3/4/5	President & CEO, Director	— class O/S missing	500,000	—	—	31 Oct 2022	3/4/5
Erin Lavelle	3/4/5	COO & CFO	— class O/S missing	170,000	—	—	31 Oct 2022	3/4/5
James B. Bucher	3/4/5	EVP and General Counsel	— class O/S missing	95,000	—	—	31 Oct 2022	3/4/5
Leone D. Patterson	3/4/5	Director	— class O/S missing	10,000	—	—	19 May 2022	3/4/5

Institutional Holders of Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) as of Q2 2023

As of 30 Jun 2023, Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,730,361 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., BML Capital Management, LLC, Driehaus Capital Management LLC, SILVERARC CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Atom Investors LP, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and BlackRock Inc.. This page lists 21 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.